UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value

International journal of cancer, 2023-07, Vol.153 (2), p.407-416

2023

Volltextzugriff (PDF)

Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group

International journal of cancer, 2022-03, Vol.150 (5), p.825-836

2022

Volltextzugriff (PDF)

The efficacy of immune checkpoint inhibitors following discontinuation for long‐term response or toxicity in advanced or metastatic non‐small‐cell lung cancers: A retrospective study

Health science reports, 2024-01, Vol.7 (1), p.e1825-n/a

2024

Volltextzugriff (PDF)

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

Cancer medicine (Malden, MA), 2018-08, Vol.7 (8), p.4023-4035

2018

Volltextzugriff (PDF)

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.653-664

2021

Volltextzugriff (PDF)

Determinants of the access to remote specialised services provided by national sarcoma reference centres

BMC cancer, 2021-05, Vol.21 (1), p.1-12, Article 631

2021

Volltextzugriff (PDF)

Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program

Supportive care in cancer, 2020-07, Vol.28 (7), p.3313-3322

2020

Volltextzugriff (PDF)

Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years

International journal of cancer, 2019-10, Vol.145 (8), p.2135-2143

2019

Volltextzugriff (PDF)

A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes

Targeted oncology, 2021-11, Vol.16 (6), p.801-811

2021

Volltextzugriff (PDF)

Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response‐Guided and Standard Treatments in HER2‐Negative Operable Breast Cancer

The oncologist (Dayton, Ohio), 2015-03, Vol.20 (3), p.243-244

2015

Volltextzugriff (PDF)

Long-term Significance (15 years) of Pathological Complete Response after Dose-dense Neoadjuvant Chemotherapy in Breast Cancer

The breast journal, 2013-07, Vol.19 (4), p.448-450

2013

Volltextzugriff (PDF)

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Cancer, 2022-01, Vol.128 (1), p.85-93

2022

Volltextzugriff (PDF)

Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort

European journal of cancer (1990), 2022-05, Vol.166, p.51-59

2022

Volltextzugriff (PDF)

Lack of prognostic value of CTNNB1 mutation profile in desmoid-type fibromatosis

Clinical cancer research, 2022-09, Vol.28 (18), p.4105-4111

2022

Volltextzugriff (PDF)

First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort

European journal of cancer (1990), 2024-01, Vol.196, p.113422-113422, Article 113422

2024

Volltextzugriff (PDF)

EGFR Exon 20 insertion: Prognostic and predictive values in advanced non-small cell lung cancer, a real-world study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9062-9062

2021

Volltextzugriff (PDF)

Impact of surgical margins on survival in cutaneous sarcomas: A nationwide study of French Sarcoma Group (FSG) from NETSARC Database

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e23537-e23537

2021

Volltextzugriff (PDF)

Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database

Journal of geriatric oncology, 2024-07, p.101819, Article 101819

2024

Volltextzugriff (PDF)

Lorlatinib for advanced ALK and ROS1+ non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9615-9615

2020

Volltextzugriff (PDF)

Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes

Nutrition and cancer, 2018-10, Vol.70 (7), p.997-1006

2018

Volltextzugriff (PDF)

Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments

Clinical breast cancer, 2018-10, Vol.18 (5), p.e1093-e1102

2018

Volltextzugriff (PDF)

Everolimus in metastatic breast cancer (MBC): Clinical experience as a late treatment line

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e11526-e11526

2015

Volltextzugriff (PDF)

Improved sarcoma management in a national network of reference centers: Analysis of the NetSarc network on 13,454 patients treated between 2010 and 2014

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11013-11013

2016

Volltextzugriff (PDF)

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line

Oncology, 2015-01, Vol.89 (6), p.319-331

2015

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Oncology
(18)
Humans
(14)
Female
(11)
Life Sciences
(11)
Cancer
(10)
Middle Aged
(9)
Adult
(8)
Patients
(8)
Chemotherapy
(7)
Male
(7)
Survival
(7)
Metastasis
(6)
Prognosis
(6)
Aged
(5)
Metastases
(5)
Sarcoma
(5)
Tumors
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value

Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group

The efficacy of immune checkpoint inhibitors following discontinuation for long‐term response or toxicity in advanced or metastatic non‐small‐cell lung cancers: A retrospective study

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

Determinants of the access to remote specialised services provided by national sarcoma reference centres

Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program

Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years

A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes

Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response‐Guided and Standard Treatments in HER2‐Negative Operable Breast Cancer

Long-term Significance (15 years) of Pathological Complete Response after Dose-dense Neoadjuvant Chemotherapy in Breast Cancer

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort

Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate

Lack of prognostic value of CTNNB1 mutation profile in desmoid-type fibromatosis

First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort

EGFR Exon 20 insertion: Prognostic and predictive values in advanced non-small cell lung cancer, a real-world study

Impact of surgical margins on survival in cutaneous sarcomas: A nationwide study of French Sarcoma Group (FSG) from NETSARC Database

Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database

Lorlatinib for advanced ALK and ROS1+ non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort

Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes

Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments

Everolimus in metastatic breast cancer (MBC): Clinical experience as a late treatment line

Improved sarcoma management in a national network of reference centers: Analysis of the NetSarc network on 13,454 patients treated between 2010 and 2014

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line

Suchergebnisse filtern